Vagner Rigaud
About Vagner Rigaud
Vagner Rigaud is a Research Scientist II at the Broad Institute of MIT and Harvard, specializing in cardiac disease biology. He has a strong academic background with extensive teaching and research experience across multiple institutions, and has published numerous articles in leading cardiovascular journals.
Current Role at Broad Institute
Vagner Rigaud currently serves as a Research Scientist II at the Broad Institute of MIT and Harvard, a position he has held since 2023. In this role, he leads a project team within the Broad-Bayer collaboration, focusing on characterizing and validating novel therapeutic candidates for cardiac diseases. His work contributes to advancing research in cardiovascular health and therapeutic development.
Previous Experience in Academia
Prior to his current position, Vagner Rigaud held various academic roles. He worked as a Postdoctoral Scientist at Temple University - Lewis Katz School of Medicine from 2019 to 2023. He also served as a Postdoctoral Scientist at the University of Coimbra in 2017 and as a Graduate Research Fellow at the Faculdade de Medicina da Universidade de São Paulo from 2007 to 2016. His teaching experience includes positions as an Assistant Teacher at Faculdade de Tecnologia e Ciências and Universidade de São Paulo.
Education and Academic Background
Vagner Rigaud has a solid educational foundation in biomedical sciences. He earned his Bachelor of Science in Genetics from UniFTC from 2003 to 2007. He then pursued a Master of Science in Biomedical Sciences at the Faculdade de Medicina da Universidade de São Paulo from 2009 to 2011, followed by a Doctor of Philosophy in Biomedical Sciences with a focus on cardiology from 2012 to 2016.
Research Contributions and Publications
Vagner Rigaud has made significant contributions to the field of cardiac disease biology, developing both in vitro and in vivo models. He has a strong publication record, with 34 publications to his name, including 17 as first or last author. His research has been featured in top cardiovascular journals, such as Circulation and the Journal of the American College of Cardiology (JACC). Additionally, he has three publications currently under review or in preparation.
Awards and Recognitions
Vagner Rigaud has been recognized for his contributions to cardiovascular research. He has been nominated for the American Heart Association (AHA) Melvin L. Marcus Early Career Investigator Award, highlighting his potential and impact in the field of cardiac research.